|
Volumn 20, Issue 11, 2001, Pages 679-681
|
Immunotherapy with β-amyloid for Alzheimer’s disease: A new frontier
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ALZHEIMER DISEASE VACCINE;
AMYLOID BETA PROTEIN[1-42];
UNCLASSIFIED DRUG;
VACCINE;
ALZHEIMER DISEASE;
ARTICLE;
CAUSE OF DEATH;
CELL LOSS;
CLINICAL TRIAL;
DEMENTIA;
DISEASE ASSOCIATION;
DISEASE COURSE;
DISEASE MODEL;
DRUG EFFICACY;
DRUG MECHANISM;
DRUG SAFETY;
HUMAN;
IMMUNIZATION;
IMMUNOTHERAPY;
NERVE CELL;
NEUROPATHOLOGY;
NONHUMAN;
PRIORITY JOURNAL;
UNITED STATES;
VACCINATION;
ALZHEIMER DISEASE;
AMYLOID BETA-PROTEIN;
ANIMALS;
DISEASE MODELS, ANIMAL;
HUMANS;
IMMUNOTHERAPY;
MICE;
MICE, TRANSGENIC;
PEPTIDE FRAGMENTS;
VACCINES;
ANIMALIA;
|
EID: 0035689761
PISSN: 10445498
EISSN: None
Source Type: Journal
DOI: 10.1089/10445490152717532 Document Type: Article |
Times cited : (23)
|
References (12)
|